Abstract
Lung cancer is the leading cause of cancer death worldwide and the majority of the patients have advanced/metastatic disease on presentation. In clinical practice, several biomarkers and clinical factors are taken into account when choosing the best treatment option in advanced Non–small cell lung cancer. Read more at JCTRes.com
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have